On-Demand Webinars

  1. Translating Stem Cell Programs To GMP 3/4/2026

    A detailed exploration of challenges in advancing stem cell programs to GMP, highlighting strategies to control variability, strengthen process design, and support reliable clinical‑stage manufacturing.

  2. Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies 3/4/2026

    Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

  3. Delivering Value In Clinical Trial Services By Managing Complexity, Timelines 3/4/2026

    Gain insights into managing global trial complexity, balancing accelerated timelines with compliance, using advanced technologies to improve efficiency, and leveraging partnerships to support seamless clinical operations.

  4. Navigating Complex Supply Chains: The Critical Role Of UK And EU Qualified Persons 3/4/2026

    Gain essential insights into QP roles, regulatory updates, and best practices for ensuring compliance, supply continuity, and safe handling of cold and frozen pharmaceutical products across the UK and EU.

  5. Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right 3/3/2026

    This session highlights common late-stage risks and discusses how a stronger stability design can support confident IND, BLA, and long-term supply strategies.

  6. USP <665> Compliance Guidance 2/26/2026

    Experts address key USP <665> questions, including risk assessment, testing approaches, extractables and leachables, and practical challenges in implementing single‑use systems in manufacturing.

  7. Re-Thinking ASD Development: When Your Molecule Breaks The Rules 2/26/2026

    A solvent‑free, fusion‑based approach streamlines amorphous solid dispersion development, enabling rapid early screening, improved performance, and sustainable manufacturing.

  8. From Brick Dust To Breakthrough: The Power Of Enabled Formulation 2/26/2026

    Enabled formulation strategies transform poorly soluble, highly lipophilic molecules into viable oral products by improving exposure, reducing burden, and ensuring manufacturable pathways.

  9. From Molecule To Milestone: Fast Track Formulation 2/26/2026

    Fast‑track, data‑driven formulation strategies align early decisions with long‑term goals, enabling First‑in‑Human progress while reducing risk, avoiding rework, and supporting manufacturable development.

  10. Navigating Complexity: Tailored Analytical & Preclinical Services 2/26/2026

    Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.